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There has been speculation as to the existence of the
mouse equivalent of human type I keratin 16 (K16). The
function of this keratin is particularly intriguing be-
cause, in normal epidermis, it is usually confined to hair
follicles and only becomes expressed in the suprabasal
intrafollicular regions when the epidermis is trauma-
tized. Previous studies suggested that K16 is highly ex-
pressed in the skin of mice carrying a truncated K10
gene. We therefore used the skin of heterozygous and
homozygous mice to create a cDNA library, and we re-
port here the successful cloning and sequencing of
mouse K16. Recent in vitro studies suggested that fila-
ments formed by human K16 are shorter than those
formed by other type I keratins. One hypothesis put
forward was that a proline residue in the 1B subdomain
of the helical domain was responsible. The data pre-
sented here demonstrate that this proline is not con-
served between mouse and human, casting doubt on the
proposed function of this proline residue in filament
assembly. In vitro assembly studies showed that mouse
K16 produced long filaments in vitro. Also, in contrast to
previous observations, transfection studies of PtK2 cells
showed that mouse K16 (without the proline) and also
human K16 (with the proline) can incorporate into the
endogenous K8/K18 network without detrimental effect.
In addition, K16 from both species can form filaments de
novo when transfected with human K5 into immortal-
ized human lens epithelial cells, which do not express
keratins. These results suggest that reduced assembly
capabilities due to unusual sequence characteristics in
helix 1B are not the key to the unique function of K16.
Rather, these data implicate the tail domain of K16 as
the more likely protein domain that determines the
unique functions.
Keratins are a family of proteins that form the intermediate
filament cytoskeleton in epithelial cells. They are divided into
two groups, the type I acidic keratins and the type II basic
keratins (1). The first step in keratin intermediate filament
(KIF)1 assembly is the formation of heterodimers between a
type I and a type II keratin (2, 3). Although any type I keratin can
bind with any type II keratin, only certain pairs of keratins exist
in vivo (4). These pairs are expressed in a tissue-type and devel-
opmentally regulated manner (5). However, for some keratins,
such as K17, a specific/unique partner has not been found.
K16 and its partner, K6, are expressed in various stratified
epithelia including those of the oral cavity, esophagus, genital
tract, and epidermis (6). In the epidermis, they are normally
confined to the hair follicles, sweat and sebaceous glands, al-
though they are also expressed in the suprabasal layer of
palmoplantar epidermis (6, 7). The expression of these two
keratins is of particular interest since, together with K17, they
are expressed in hyperproliferative situations such as benign
and malignant tumors, keratinocytes in culture, hyperprolif-
erative skin diseases such as psoriasis, and wound healing
(8–11). K6, K16, and K17 are therefore sometimes referred to
as the “hyperproliferation-associated” keratins. Often associ-
ated with the expression of these keratins is the down-regula-
tion of the differentiation-specific keratins 1 and 10, which
normally predominate in the suprabasal epidermis (12). In
vitro studies suggest that K16 has unique properties that could
affect the structural organization of KIFs (13). Specifically, K16
appears to form shorter filaments than K14 with the type II
keratins K5 and K6a. If this property of making shorter fila-
ments is important for the modulation of keratinocyte behavior
via alterations in the cytoskeleton during wound healing and in
hyperproliferating keratinocytes, then the K16 sequence would
be expected to be highly conserved among mammalian species.
Mutations in keratin genes, including K16, have now been
identified as the underlying cause of several inherited epithe-
lial disorders (14). Mutations in human K16 (hK16) result in
pachyonychia congenita type I, which is characterized by nail
dystrophy, focal palmoplantar keratoderma, and oral keratoses
reflecting the expression pattern of this keratin (15). Despite
the apparently important functions of K16 in humans, there
has been some speculation as to the existence of a K16 gene in
mice (16). Using a mouse model for the inherited skin disease
bullous congenital ichthyosiform erythroderma, our previous
studies suggested that K16 is highly expressed in the acan-
thotic epidermis of these mice (17). Although there is some
evidence to suggest that the hyperproliferation-associated
keratins are controlled, at least in part, post-transcriptionally
(18), we observed a significant increase in the putative mRNA
levels of K16 in K10 mutant mice. It therefore seemed logical to
assume that a cDNA library generated from the skin of these
mutant mice would facilitate the isolation of the gene for mouse
K16 (mK16). Here we describe the cloning and sequencing of a
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complete cDNA for mK16 isolated from such a library made
from the skin of K10 mutant mice. Using the mK16 cDNA, in
vitro assembly studies and transfection studies were carried
out to assess previous hypotheses relating specific K16 se-
quences to function.
MATERIALS AND METHODS
Cloning and Sequence Analysis of mK16 cDNA—Skin was removed
from three homozygous, two heterozygous, and one wild-type neonatal
C57Bl6 mouse as described previously (17). mRNA was extracted using
a Quickprep micro mRNA purification kit (Amersham Pharmacia Bio-
tech). cDNA synthesis and library construction were carried out using
a Zap Express cDNA synthesis kit (Stratagene, Cambridge, United
Kingdom). The library was screened with a probe prepared by polym-
erase chain reaction of hK16 cDNA using the forward primer CTG-
GCTTTGGTGGTGGTTT and the reverse primer AGGCAGCTCAGT-
TCTAGGAGC (40 cycles of denaturing at 94 °C for 30 s, annealing at
55 °C for 30 s, and synthesis at 72 °C for 1 min). Random-primed DNA
labeling of the probe with digoxigenin was carried out using a DIG-high
prime labeling and detection kit (Boehringer Mannheim). The probe
was diluted to 10 ng/ml in standard buffer and 50% formamide and
hybridized at 37 °C overnight. The filters were washed two times in 23
SSC (203 SSC 5 3 M sodium chloride, 300 mM sodium citrate), 0.1%
SDS at room temperature (5 min) and two times in 0.53 SSC, 0.1% SDS
at 55 °C (15 min). Positive colonies were detected by a colorimetric
method using nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl
phosphate (Sigma, Poole, UK) as described in the manufacturer’s in-
structions. The positive clones were excised as pBK-CMV phagemids
and sequenced with T3 or M13 primers using an automated sequencer
(ABI 377). Mouse cDNA, excised by an EcoRI/XhoI digestion from a
pBK-CMV phagemid and labeled as described above, was used as a
probe to screen for longer length clones.
To obtain the sequence of the 59-end, the rapid amplification of cDNA
ends (RACE) protocol was followed using a RACE kit (Boehringer
Mannheim). The following primers were used for amplification: SP1,
GGATCTTCACCTCCAGGTCTC; SP2, CCACCAAATCCACTACCAAG-
TCC; and SP3, CTGCTGAAGCTCCCACCATAG. Sequencing of the
RACE product was achieved using the SP3 primer. Complete sequence
analysis of mK16 cDNA was obtained using the forward primers F1
(GACCATTGAGGACCTGAAGAG), F2 (TGTATGCAGCTGTCCCAGA-
TC), F3 (CCTCAGCATGGCCACCTGCAG), and F4 (CTGAGGAGCTG-
AACAAAGAGG) and the reverse primers R1 (ATCTGGGACAGCTGC-
ATACAG), R2 (AGCCTGGCATTGTCAATCTGC), R3 (GGCAGTTGTG-
GGTGAGGAGGC), and SP1 (see above). We were also able to sequence
the mK14 clone 5.1 using the mK16 primers R1 and F1 and the plas-
mid-specific primers T3 and M13(220).
Immunofluorescence—A polyclonal antibody to mK16 (RPmK16) was
obtained by immunizing rabbits with the C-terminal peptide GSTS-
FSQSQSQSSRD of mK16 linked to keyhole limpet hemocyanin. Frozen
sections were fixed in methanol/acetone (1:1) at 220 °C for 5 min and
incubated with RPmK16 diluted 1:500 in phosphate-buffered saline (pH
7.5) for 1 h at room temperature. The secondary antibody was fluores-
cein isothiocyanate-conjugated goat anti-rabbit IgGs (Sigma). Slides
were mounted in 10% Mowiol, 2.5% diazabicyclo[2.2.2]octane (Sigma).
Tranfection of mK16 cDNA into PtK2 Cells—Complete mK16 was
created by reverse transcription-polymerase chain reaction from RNA
extracted from K10 heterozygous mouse skins using Taq polymerase,
forward primer F3, and reverse primer R3 and cloned into pGEM
(Promega). Five clones were sequenced in both directions, and one clone
with a single silent mutation was selected for subcloning of the mK16
cDNA into the EcoRI site of the expression vector pcDNA3 (Invitrogen).
Transfection was carried out on subconfluent PtK2 cells grown on
13-mm2 glass coverslips using the calcium phosphate precipitation
method. cDNAs of hK14 and hK16 cloned into pcDNA3 were used as
controls. A mutant hK16 in pCR3 was also transfected. This cDNA was
obtained from a patient with pachyonychia congenita and contains an
L130P mutation. At 24, 48, and 72 h after transfection, the cells were
fixed for 1 min at 220 °C in methanol/acetone (1:1). RPmK16 was
diluted in phosphate-buffered saline (1:500), and LL025 (K16), LL001
(K14), LE65 (K18) were applied undiluted. All primary incubations
were for 1 h. After washing coverslips in H2O, Cy3-conjugated goat
anti-rabbit IgGs (heavy and light chains; Jackson ImmunoResearch
Laboratories, Inc., Stratech, UK), fluorescein isothiocyanate-conjugated
sheep anti-mouse antibodies (Sigma), or goat anti-rabbit antibodies
(Sigma) were diluted 1:50 in phosphate-buffered saline and incubated
for 30 min. Coverslips were mounted in Citifluor (Agar, Stansted, UK)
and sealed with nail varnish.
After removing coverslips from the culture dishes, the remaining
cells were scraped from the dish and solubilized in SDS sample buffer
(100 ml). One-dimensional SDS-PAGE and immunoblotting were car-
ried out as described previously (19). Primary antibodies were diluted
as follows: LE65 and LL025 (1:5) and RPmK16 (1:5000) in Tris-buffered
saline, 0.1% Tween 20. Secondary antibodies were anti-mouse or anti-
rabbit immunoglobulins conjugated to alkaline phosphatase diluted
1:1000 (Dako, Bucks, UK). Detection was with nitro blue tetrazolium/
5-bromo-4-chloro-3-indolyl phosphate.
Transfection of Eye Lens Cell Line H36CEI—H36CEI cells are de-
rived from human epithelial cells of the eye lens (20). Subconfluent cells
grown on 13-mm 2 glass coverslips were individually transfected in a
well of a 24-well plate with 0.6 mg of mK16, hK16, hK5, or hK14 cDNA
in pcDNA3. Double transfections were with 0.3 mg of hK5 cDNA and 0.3
mg of each type I keratin cDNA. Transfection was achieved by linking
the plasmid DNA to inactivated adenovirus particles (5 3 108) using 10
mM polyethyleneimine as described previously (21). Staining was car-
ried out as described for PtK2 cells. Polyclonal antibody BL-18 to K5
was diluted 1:500 in phosphate-buffered saline.
Keratin Expression in Bacteria and Purification—hK5, mK16, and
hK16 cDNAs were generated with an NdeI restriction site introduced at
the beginning by reverse transcription-polymerase chain reaction using
a 59-primer with a 3-base pair extension of CAT. After sequencing to
check that no errors had been incorporated, the cDNAs were cloned into
pT7-7 (mK16) (22) or pET-23b (hK16 and hK5) (Novagen) vectors.
These plasmids were individually transformed into Escherichia coli
strain BL21(DE3) pLysS and grown to A600 ; 0.5 before inducing
protein expression with isopropyl-b-D-thiogalactopyranoside (0.5 mM)
for 4 h. Inclusion body preparation was carried out as described previ-
ously (23). Keratins were purified by ion-exchange chromatography
using a Merck-Hitachi Biochromatography system with a 10 3 150-mm
Fractogel-EMD DEAE-650S column (Merck) equilibrated in 8 M urea,
20 mM Tris-HCl (pH 8), 2 mM EDTA, 1 mM dithiothreitol. Fractions of 2
ml were eluted with a linear salt gradient of 0–0.4 M NaCl over 40 min
at 1 ml/min and analyzed by SDS-PAGE.
In Vitro Filament Assembly and Electron Microscopy—Recombinant
type I and II keratins were mixed in a 1:1 molar ratio at a concentration
of 0.2 mg/ml. Assembly was achieved either by a rapid dialysis proce-
dure against 2.5 mM Tris-HCl (pH 7.5), 25 mM 2-mercaptoethanol at
4 °C for 16–20 h (13, 24) or by a staged dialysis procedure essentially as
described (25). Briefly, samples in 8 M urea-containing buffer were
dialyzed in 4 M urea-containing buffer and then in 10 mM Tris-HCl (pH
8.0), 25 mM 2-mercaptoethanol. An additional dialysis against Tris-HCl
(pH 7.5) was included for direct comparison with the rapid dialysis
procedure. The assembly was completed in 10 mM Tris-HCl (pH 7.0), 50
mM NaCl, 1 mM MgCl2, 25 mM 2-mercaptoethanol. Assembly was mon-
itored at all stages by electron microscopy. Proteins were diluted to 1:10
and negatively stained using 1% (w/v) uranyl acetate. Grids were ex-
amined in a Jeol 1200EX transmission electron microscope using an
accelerating voltage of 80 kV.
Sedimentation Assay—The efficiency of filament formation was as-
sessed by sedimentation assay (25, 26). Briefly, the assembly mixture
was layered on top of 0.85 M sucrose in the final assembly buffer and
centrifuged for 30 min at 80,000 3 g at 20 °C in a Beckman TLS-55
rotor using a TL100 bench-top ultracentrifuge. The final pellet was
dissolved directly in SDS-PAGE sample buffer, and the remaining
protein in the supernatant was precipitated (27) before also being
resuspended in sample buffer. Both protein samples were dissolved in
volumes directly proportional to the original sample volume for direct
comparison by SDS-PAGE.
RESULTS
cDNA Cloning and Sequencing of mK16—We have gener-
ated a Zap Express mouse cDNA library from the skin of mice
created as a model for the skin disease bullous congenital
ichthyosiform erythroderma. Using the hK16 probe, two mK16
clones (4.2 and 8.1) and one K14 clone (5.1) were isolated as
pBK phagemids. None of the clones contained full-length ker-
atin cDNAs, so the library was rescreened with mK16 cDNA
from the longer of the two clones. Two additional clones con-
taining K16 were obtained (7.31 and 2.11), the largest of which
was 50 base pairs short of the 59-end (clone 7.31). The shared
sequence of all four clones was identical. We obtained the
59-sequence including the start codon and 10 base pairs of
untranslated sequence using RACE. The complete cDNA se-
cDNA Cloning of mK1632266
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quence obtained from sequence analysis of the clones and the
RACE product is shown in Fig. 1. When scanned against the
data base, the sequence is most highly related to hK16 (Gen-
BankTM accession number S79867). After the TAA stop codon,
there is a 157-base pair untranslated region including a poly(A)
addition signal (AATAAA) and an 18-residue poly(A) tail.
The K14 clone 5.1 was identical in sequence to the mK14
clone pkSCC52 reported previously (GenBankTM accession
number J02644) (28). Our sequence analysis extends the mK14
sequence by an additional 17 amino acids upstream of QNLN-
DRLATY. The additional amino acids are identical to mK16.
Comparison of mK16 Amino Acid Sequence with Other Ker-
atin Sequences—The sequence codes for a protein of 469 amino
acids with a calculated Mr of 51,514. All keratins have struc-
tural similarities, including an a-helical rod domain inter-
rupted by short non-helical linker regions and non-helical head
and tail domains. The rod domain is bounded by the highly
conserved helix initiation and helix termination motifs and
consists of four segments (1A, 1B, 2A, and 2B) of conserved
length (29). The sequence of mK16 is 85% homologous to that of
hK16 (Fig. 2), with the central a-helical rod domain being most
highly conserved (89% identical over 308 amino acids starting
at KVTMQNLNDRLATY and finishing at TYRRLDGE). The
helix initiation motif differs from that of hK16 in that it con-
tains a threonine rather than a serine. Although mutations in
this motif can cause very severe disorders, this particular
change is apparently tolerated and is also observed in mK14
(28). The helix termination motif also differs from that of hK16
by one amino acid residue; in this case, an aspartic acid residue
replaces a glutamic acid residue. This glutamic acid is highly
conserved in epithelial keratins; however, an aspartate is seen
at this position in type I hard a-keratins found in hair and in
CP49/phakinin, an intermediate filament protein of the eye
lens (29–32). A significant difference in the a-helical region is
the lack of the proline residue in the 1B domain that has been
postulated to be responsible for the formation of rather shorter
keratin filaments by hK16 (13). The head domain of mK16
shares 71% homology with hK16, over the first 113 amino acids
of mK16. This region of hK16 has sequence that is identical to
that of hK14 and hK17 (see Troyanovsky et al. (44) for an
alignment). Of these shared residues, 88% are conserved in the
mouse sequence. In the tail domain, 70% of mK16 amino acids
are present in hK16. Of particular note, 13 of the last 19
residues of hK16 are conserved. This region bears no homology
to hK14 or hK17 and is likely to make K16 unique.
Mouse-specific K16 Polyclonal Antibody—The C terminus of
FIG. 1. Nucleotide sequence and deduced amino acid sequence of mouse keratin 16 cDNA. The sequence obtained from the largest clone
(7.31) and the RACE product includes 10 base pairs upstream of the initial codon coding for methionine and 157 base pairs of 39-untranslated
sequence.
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mK16 is longer than that of hK16 and contains two additional
charged residues. Therefore, it is perhaps of no surprise that a
polyclonal antibody (RPmK16) raised against the last 15 amino
acid residues has proved to be specific for mK16 and does not
recognize hK16. We have tested the antibody on human skin
specimens including scalp, axilla, thigh, face, breast, lip, pal-
ate, and finger and observed no staining of hair follicles or
suprabasal epidermis, as is readily seen with the monoclonal
antibody to hK16 (LL025) (33). Similarly, the human keratino-
cyte cell line HaCaT, which constitutively expresses K16, did
not stain with RPmK16 (34). Mouse epidermis, however, was
recognized by this antibody. Hair follicles and whisker follicles
were positive in normal mouse epidermis (data not shown).
Also, positive staining of the suprabasal layer of the acanthotic
epidermis of K10 mutant mice was observed (data not shown)
and was similar to the results obtained with LL025 (35).
Transfection of PtK2 Cells with mK16 cDNA—Previous stud-
ies have reported that forced expression of hK16 in PtK2 cells
causes the endogenous K8/K18 network to retract from the
cytoplasmic periphery (13, 24). This reorganization was de-
scribed as increasing with time, and at 72 h post-transfection,
.50% of the transfected cells showed a juxtanuclear location of
the keratin filaments (13). We therefore chose this time point to
examine the effect of transfected mK16 in PtK2 cells. In 95% of
the transfected cells, mK16 was incorporated into the existing
K8/K18 network, forming normal filaments at 72 h post-trans-
fection (Fig. 3a). In the remainder of the cells, small regular
circular structures were observed (Fig. 3b), as described in other
transfection experiments of PtK2 cells with normal and mutant
human keratins (36–38). No perinuclear keratin filaments were
observed comparable to those described by Paladini et al. (13).
At 24 h post-transfection, mK16 had already incorporated into
the endogenous K8/K18 filament matrix as shown by double
immunofluorescence microscopy (Fig. 3, c and d).
For comparison, we also transfected PtK2 cells with plas-
mids containing either hK16 (containing the proline in coil 1B)
or hK14 cDNA. Similar well extended filaments were observed
as well as some small spherical aggregates found in 5% of the
transfected cells (Fig. 3e). Retracted filaments (13, 24) were
only observed in transfections with K16 cDNA carrying a point
mutation (L130P) obtained from a patient with pachyonychia
congenita (Fig. 3f).
Both the monoclonal antibody to hK16 (LL025) and the poly-
clonal antibody RPmK16 were used to stain transfected cells
(33). Whereas LL025 stained cells transfected with either
mK16 or hK16, RPmK16 only stained cells transfected with
mK16. Analysis of transfected cells by immunoblotting showed
hK16 and mK16 to have similar relative mobilities on SDS-
polyacrylamide gels and confirmed the species specificity of
RPmK16 (Fig. 4).
Transfection of mK16 into H36CEI Cells—To determine if
mK16 could form filaments in the absence of an established
keratin network, we carried out cotransfections of mK16 with
hK5 into a human lens epithelial cell line (H36CEI). This cell
line has vimentin (but not keratin) intermediate filaments (20).
At 24 h post-transfection, .50% of the transfected cells showed
extensive networks of keratin filaments when stained with
BL-18 (Fig. 5a). The filaments formed were comparable to
those obtained in double transfections of hK14 or hK16 with
hK5 in a similar percentage of transfected cells (Fig. 5, b and c).
The remainder of the transfected cells either had not formed
filaments or contained very short filaments. Sometimes large
clumps of keratins were seen in the cells. These irregular
filaments were seen in K5/K14-transfected cells as well as in
K5/K16-transfected cells. No filaments were formed in single
transfections.
In Vitro Assembly of mK16—The assembly properties of
mK16 were of particular interest due to the report that hK16,
FIG. 2. Comparison of amino acid sequences of mK16 and hK16. The amino acid sequences are optimally aligned. Dashes were introduced
to obtain optimal alignment of residues. Lines were drawn to indicate identical residues, and asterisks denote non-identical residues.
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under certain conditions, forms shorter filaments with hK5/
hK6 than does hK14 (13). Keratins from human and mouse
were expressed in bacteria and purified by ion-exchange chro-
matography for in vitro assembly studies. Two different meth-
ods of assembly were performed; one used a rapid dialysis
procedure, and the other employed a staged dialysis procedure
to remove the urea from the protein solution. In both cases, the
type I keratins were mixed in a 1:1 molar ratio with hK5. The
rapid dialysis procedure was achieved by overnight dialysis
into 2.5 mM Tris (pH 7.5) from 8 M urea-containing buffers.
These conditions produced shorter filaments for a K5/K16 pair-
ing than for K5/K14 (13, 24). Under these assembly conditions,
hK16 with hK5 formed numerous very short filaments (Fig.
6a), similar to those observed previously (13). In contrast,
mK16 and K5 formed an abundance of much longer filaments
(Fig. 6c). Using the staged dialysis procedure, both mK16 and
hK16 formed long filaments at pH 7.5 (Fig. 6, b and d).
To assess the efficiency of the in vitro assembly experiment,
a sedimentation assay was performed. In agreement with the
electron microscopy results, the K5/hK16 filaments in the rapid
dialysis procedure were not efficiently sedimented due to their
short length (data not shown), unlike the K5/mK16 filaments,
which sedimented under the conditions of the assay (Fig. 7).
Addition of 50 mM salt to the assembly mixture promoted
complete assembly of both keratins. The staged dialysis of
keratins also led to complete assembly of keratin filaments
(data not shown).
DISCUSSION
This study demonstrates unequivocally the existence of a
mouse gene for K16. The amino acid sequence of mK16 is 85%
homologous to that of hK16. hK16 possesses a proline in the
helix 1B segment (13). This is not a unique situation, as an-
other intermediate filament (CP49ins) possesses a proline in a
similar position (32). Proline residues are not usually seen in
helical proteins, and they would be expected to disrupt the
regular helicity of the structure (39, 40). This proline, it was
reasoned, could be responsible for the shorter filaments formed
when K16 rather than K14 was assembled in vitro or in fibro-
blasts with either K5 or K6b. In other positions in the a-helix,
FIG. 3. Staining of transfected PtK2
cells. PtK2 cells transfected with mK16
and stained with RPmK16 72 h post-
transfection showed excellent formation
of mK16-containing filaments in 95% of
the transfected cells (a) and spherical
bodies in the remaining 5% (b). PtK2 cells
transfected with mK16 at 24 h post-trans-
fection and co-stained with RPmK16/flu-
orescein isothiocyanate for mK16 (c) and
with LE65/Cy3 for KIFs (d) clearly
showed incorporation into the endoge-
nous keratin intermediate filament net-
work. PtK2 cells transfected with hK16
and stained with LL025 also showed nor-
mal keratin intermediate filaments (e).
Abnormal filaments were observed in
cells transfected with hK16 with a L130P
mutation (f). LE65 staining is shown so
that normal PtK2 keratin filaments can
be compared with the abnormal retracted
filaments in the cell in the center of the
picture.
FIG. 4. Western analysis of transfected cells. Lanes 1 and 3,
hK16-transfected cell lysate stained with LL025 and RPmK16, respec-
tively; lanes 2 and 4, mK16-transfected cell lysate stained with LL025
and RPmK16, respectively. Molecular masses are indicated on the right
in kilodaltons.
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a proline can be detrimental to KIF assembly, and in many
epidermal keratins including K16, such a proline can lead to
skin disease (41). In one study, a proline residue was intro-
duced experimentally into the a-helical domain at a number of
different points; however, an effect on filament assembly was
observed only when it was introduced at the ends of the helical
region (42). To support the possibility that the proline could be
responsible for the unique properties of K16, Wawersik et al.
(24) replaced this residue with valine, the corresponding amino
acid in hK14, and showed that hK16 could be made to form
more stable tetramers. The mouse sequence for K16 lacks this
proline residue, which is replaced by a phenylalanine (see
Phe-191 in Fig. 2). As this proline is not conserved between
mouse and human, it is unlikely to play a key role in the
function of K16.
There are several published sequences for hK16 with and
without the proline residue (43–46), and it is possible that
several different K16 genes exist, as observed with K6 (47).
FIG. 5. Transfection of keratins into lens cell line H36CEI. H36CEI cells were transfected with hK5 and hK14 (a), hK5 and hK16 (b), and
hK5 and mK16 (c). All cells were stained with BL-18/Cy3 and the corresponding monoclonal antibody to the type I keratin/fluorescein isothio-
cyanate. BL-18/Cy3 staining is shown in each case.
FIG. 6. Electron micrographs of K5/
K16 filaments assembled in vitro. K5/
hK16 formed short filaments (a) when as-
sembled by the rapid dialysis procedure
and long filaments (b) using the staged
dialysis procedure. K5/mK16 formed long
filaments using the rapid dialysis proce-
dure (c) and the staged dialysis procedure
(d). Scale bar 5 250 nm.
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However, no other evidence suggesting more than one hK16
gene exists at present. In our experience, the human sequence
containing the proline (GenBankTM accession number S79867)
is the correct one. All four mK16 clones obtained from the
expression library in this study were of identical sequence, so
we would expect that the sequence reported here (without the
proline in coil 1B) is the predominant form of mK16, if not the
only form.
Our data do indicate some differences in the in vitro assem-
bly properties of hK16 and mK16. For instance, mK16 forms
long filaments using the rapid dialysis procedure, whereas
hK16 produces only short filaments with an identical type II
partner. Long filaments can be produced in vitro with hK16 or
mK16 with hK5 by the staged dialysis procedure. The results
obtained using the two methods suggest that hK16 and mK16
have different assembly properties, which may be due to se-
quence differences between the two keratins. The proline res-
idue is likely to be at least partly responsible for these differ-
ences since it has been shown by mutation analysis to affect
tetramer stability (24). The reduced tetramer stability of hK16
may mean that this keratin requires more time to reach an
energetically favorable state, as provided by the staged dialysis
procedure. The weaker interactions at the tetramer stage do
not, however, affect the end point of assembly in vitro where
both hK16 and mK16 form long filaments. There are also no
apparent differences when filaments assemble in transiently
transfected cells. The fact that the mouse protein does not
share the in vitro filament assembly properties of the human
protein suggests that the assembly pathway is secondary to the
unique function of this keratin.
In contrast to previous studies (13, 24), we observed no
irregularity of the KIF cytoskeleton in K16 transfection stud-
ies. In PtK2 cells, we see that both mouse and human K16 are
capable of incorporating into the existing K8/K18 keratin fila-
ments. We only see irregular filament formation when the
transfected keratin gene carries a pathogenic point mutation as
found in patients with keratin disorders. It is possible that the
different observations can be accounted for by varying levels of
expression of the K16 constructs. However, we used the same
method of transfection with an identical expression vector as
Paladini et al. (13), and we would therefore expect similar
transfection efficiencies. Also, both mK16 and hK16 form fila-
ments similar to those formed by hK14 and hK5 in the lens
epithelial cell line H36CEI. One possible explanation for these
differences from previously published data (13) is a difference
in K16 sequence. The original clone of hK16 sequenced by
Paladini et al. (43) begins with the sequence MAT rather than
MTT, which is an error caused by a cloning artifact. Other than
this very minor difference, our hK16 is identical in sequence.
This variation is unlikely to explain the different observations,
as the mouse sequence also begins with MAT not MTT, but at
present, it is the only apparent difference to explain the two
sets of results.
Subtle differences in the a-helical domain may lead to dif-
ferent filament-forming abilities and cytoskeletal rigidity.
However, the sequence of mK16 shows a high degree of amino
acid sequence conservation to hK14, hK17, and hK16 in the
a-helix (44). There is also a high degree of sequence homology
(83%) between mK14 and mK16 in the a-helical rod domain
(28). The most unique amino acid sequences of individual kera-
tins are found in the head and tail domains. Common features
are observed between keratins with similar expression pat-
terns. For example, the end domains of both type I and II
keratins of simple epithelial keratins are rich in serine resi-
dues, whereas those of complex epithelia are rich in glycine
residues, and hair keratins are rich in cysteine (48). It seems
therefore likely that these domains should at least be partly
responsible for the individuality of the keratin molecule. So far,
too few disease-causing mutations have been identified in the
head and tail domains to give clues as to the function of the
head and tail domains (reviewed in Ref. 14). The most unique
region of K16 is found in the C terminus since it shows 70%
homology (over 49 residues) to hK16, but only 12% homology to
the C terminus of mK14. In contrast, the N terminus of mK16
is 72% homologous to that of hK14.
In conclusion, it would appear there is little unusual about
the assembly properties of K16 that are likely to be functionally
significant for the following reasons. 1) Our transfection stud-
ies show that K16 can not only integrate into an existing
keratin network, but can also form filaments de novo in vivo. 2)
The decreased assembly capability of hK16 in vitro only occurs
under certain conditions and is not apparently shared by
mK16. 3) Both hK16 and mK16 are equally capable of forming
long filaments in vitro with K5. The restricted distribution of
K16 in normal tissue and its altered expression pattern in
hyperproliferative states such as wound healing and tumori-
genesis suggest a specific and specialized role for this keratin.
The existence of a mK16 strengthens the evidence for an es-
sential role for this protein that is not provided by other kera-
tins. The unique sequence of the tail domain of K16 is highly
conserved between mouse and human and is a favored candi-
date to provide clues to the function of this protein. Mutation
analysis by genetic manipulation could be useful to resolve this
issue.
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